MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,329 | +45.9% | 2,637 | +19.4% | 0.00% | +50.0% |
| Q2 2023 | $57,121 | +99.5% | 2,208 | +85.2% | 0.00% | +100.0% |
| Q1 2023 | $28,632 | +11.9% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,580 | +2.3% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | +8.7% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | +360.0% | 1,192 | +429.8% | 0.00% | – |
| Q1 2022 | $5,000 | +25.0% | 225 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 225 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 225 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +200.0% | 225 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |